Home>
Stocks>
Ortin Laboratories Ltd

Ortin Laboratories Ltd Share Price (ORTINLAB)

₹19.55▲1.03%

Get free price alerts. Set up your Free investment account to get Live Prices. >

Overview

Fundamentals

Q3 '23 Results

Technicals

News and Events

Ortin Laboratories Ltd share Performance

₹19.1
₹19.95
₹19.55
2.30%
Low
Day's Volatility:4.35%
High
2.05%
₹16.2
₹30.35
₹19.55
17.14%
Low
52 Weeks Volatility:72.38%
High
55.24%

Returns %
1 Month Return	12.5 %
3 Month Return	-5.38 %
1 Year Return	-1.02 %

Market Stats
Previous Close	₹19.35
Open	₹19.95
Volume	6,350.00
Upper Circuit	-
Lower Circuit	-
Market Cap	₹15.73Cr

Company Information

Ortin Laboratories Ltd is a leading Pharmaceutical Manufacturer in India offering a range of quality drugs and medicines since 1986. They have constructed a manufacturing unit equipped with technically modern facilities, certified by ISO 9001: 2000, located at Medak in Andhra Pradesh. Their product offerings include anti arthritic drugs, antibiotics, chemo therapeutics, analgesics, cardiac and cardio vascular drugs, and a variety of other drugs. In 200304 they started their products marketing in various states and got the company listed in BSE Indonext in 200607. The company has gone on to export their products to African, Asian and Middle Eastern countries and achieved the National Drug Authority Uganda certification in 200910. In 201011 they acquired Vineet Laboratories Pvt Ltd and were allotted 6.18 acres of land from APIIC for the construction of USFDA and European Standard Bulk Drug manufacturing.

Share Price: ₹19.55 per share as on 23 Apr, 2024 04:01 PM
Market Capitalisation: ₹15.73Cr as of today
Revenue: ₹13.16Cr as on June 2012 (Q2 12)
Net Profit: ₹0.44Cr as on June 2012 (Q2 12)
Listing date: 21 Aug, 2015
Chairperson Name: J R K Panduranga Rao

Organisation	Ortin Laboratories Ltd
Headquarters
Industry	Pharmaceuticals
E-voting on shares	Click here to vote

Fundamentals of Ortin Laboratories Ltd

Insights on Ortin Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 92.63% to 92.64% in Dec 2023 quarter
NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 141.4% return, outperforming this stock by 179.7%
NO EFFECT
Against Peers
In the last 1 year, Sun Pharmaceuticals Industries Ltd has given 57.3% return, outperforming this stock by 58.3%
NEGATIVE IMPACT
Price Dip
In the last 3 years, ORTINLAB stock has moved down by -38.3%
NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 7.37% to 7.36% in Dec 2023 quarter